YARROW BIOSCIENCE, INC. Income (Loss) from Continuing Operations, Per Diluted Share
YARROW BIOSCIENCE, INC. (YARW) reported Income (Loss) from Continuing Operations, Per Diluted Share of -$3.38 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare · last filed 2026-08-13
- YARROW BIOSCIENCE, INC. income (loss) from continuing operations, per diluted share for the quarter ending 2026-06-30 was -$3.38.
- YARROW BIOSCIENCE, INC. income (loss) from continuing operations, per diluted share for the quarter ending 2026-03-31 was -$0.08.
- YARROW BIOSCIENCE, INC. income (loss) from continuing operations, per diluted share for the quarter ending 2025-06-30 was -$6.72.
- YARROW BIOSCIENCE, INC. income (loss) from continuing operations, per diluted share for the quarter ending 2025-03-31 was -$0.20.
- YARROW BIOSCIENCE, INC. income (loss) from continuing operations, per diluted share for fiscal 2023 was -$2.72.
- YARROW BIOSCIENCE, INC. income (loss) from continuing operations, per diluted share for fiscal 2022 was -$10.65.
- YARROW BIOSCIENCE, INC. income (loss) from continuing operations, per diluted share for fiscal 2021 was -$15.46.
| Period end | Income (Loss) from Continuing Operations, Per Diluted Share 3 month | Income (Loss) from Continuing Operations, Per Diluted Share 3 month as first filed | Income (Loss) from Continuing Operations, Per Diluted Share 6 month | Income (Loss) from Continuing Operations, Per Diluted Share 6 month as first filed | Income (Loss) from Continuing Operations, Per Diluted Share 9 month | Income (Loss) from Continuing Operations, Per Diluted Share 9 month as first filed | Income (Loss) from Continuing Operations, Per Diluted Share 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$3.38 10-Q · filed 2026-08-13 | -$7.56 10-Q · filed 2026-08-13 | |||||
| 2026-03-31 | -$0.08 S-4/A · filed 2026-06-03 | ||||||
| 2025-12-31 | -$0.63 S-4/A · filed 2026-06-03 | ||||||
| 2025-06-30 | -$6.72 10-Q · filed 2026-08-13 | -$0.13 10-Q · filed 2025-08-14 | -$16.80 10-Q · filed 2026-08-13 | -$0.34 10-Q · filed 2025-08-14 | |||
| 2025-03-31 | -$0.20 S-4/A · filed 2026-06-03 | ||||||
| 2024-12-31 | -$0.93 S-4/A · filed 2026-06-03 | ||||||
| 2024-09-30 | -$0.29 10-Q · filed 2024-11-07 | -$0.65 10-Q · filed 2024-11-07 | |||||
| 2024-06-30 | -$0.22 10-Q · filed 2025-08-14 | -$0.37 10-Q · filed 2025-08-14 | |||||
| 2024-03-31 | -$0.15 10-Q · filed 2025-05-08 | ||||||
| 2023-12-31 | -$2.72 10-K · filed 2025-03-06 | ||||||
| 2023-09-30 | -$1.85 10-Q · filed 2024-11-07 | -$6.66 10-Q · filed 2024-11-07 | |||||
| 2023-06-30 | -$3.08 10-Q · filed 2024-08-14 | -$4.81 10-Q · filed 2024-08-14 | |||||
| 2023-03-31 | -$1.74 10-Q · filed 2024-05-09 | ||||||
| 2022-12-31 | -$10.65 10-K · filed 2024-03-01 | ||||||
| 2022-09-30 | -$2.88 10-Q · filed 2023-11-13 | -$0.16 10-Q · filed 2022-11-14 | -$8.25 10-Q · filed 2023-11-13 | -$0.46 10-Q · filed 2022-11-14 | |||
| 2022-06-30 | -$2.56 10-Q · filed 2023-08-14 | -$0.14 10-Q · filed 2022-08-12 | -$5.38 10-Q · filed 2023-08-14 | -$0.30 10-Q · filed 2022-08-12 | |||
| 2022-03-31 | -$2.83 10-Q · filed 2023-05-11 | -$0.16 10-Q · filed 2022-05-12 | |||||
| 2021-12-31 | -$15.46 10-K · filed 2023-03-14 | ||||||
| 2021-09-30 | -$0.27 10-Q · filed 2022-11-14 | -$0.71 10-Q · filed 2022-11-14 | |||||
| 2021-06-30 | -$0.21 10-Q · filed 2022-08-12 | -$0.43 10-Q · filed 2022-08-12 | |||||
| 2021-03-31 | -$0.22 10-Q · filed 2022-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |